ROSTANOIDS ARE cyclooxygenase metabolites of arachidonic acid and are one of the regulatory factors erythroid), 24 HL-60 (granuloid), 25 THP-1 (monocytoid), 26 MOLT4
maintaining homeostasis in the body such as vitamins and (T-lymphoid), 27 MM-S1 (myeloma), 28 and U266 (myeloma) 29 were
hormones. Prostanoids, synthesized in various organs, act Raynaud's syndrome. 6 Prostacyclin exhibits its activities via binding to its specific membrane receptor, PGI 2 -R which Recombinant Human Cytokines and Chemical Reagents exists widely in the heart, aorta, kidney, and platelets. [7] [8] [9] [10] It is well known that PGI 2 -R is abundantly expressed on plateRecombinant human cytokines and their respective concentrations lets. The number of PGI 2 -R on platelets decreases in the employed in culture are as follows: interleukin-1a (IL-1a) (100 U/ active phase of spontaneous angina pectoris 11 and in acute myocardial infarction, 12 while that of TxA 2 receptor in- PGI 2 -R expression on megakaryocytes have been performed
Submitted November 18, 1996; accepted March 25, 1997. only by two groups; they showed binding of prostanoids to mL), IL-1b (10 ng/mL), IL-3 (10 ng/mL), IL-6 (10 ng/mL), granulo-
Binding Assay
cyte colony-stimulating factor (G-CSF) (10 ng/mL), granulocyte-HEL and NS-Meg cells were precultured for 48 hours with or macrophage (GM)-CSF (10 ng/mL), tumor necrosis factor-a (TNFwithout (control) either PMA or TPO, then harvested and washed a) (10 ng/mL), erythropoietin (EPO) (5 U/mL), and thrombopoietin twice with RPMI 1640 medium, then suspended (1 1 10 6 cells/tube) (TPO) (10 ng/mL). IL-1a and TNFa was kindly provided by Dainipin 20 mmol/L Tris-HCl pH 7.4. Binding assay was performed with pon Pharmaceutical Co (Osaka, Japan), IL-1b by Otsuka Pharmaceu-50 nmol/L of [ 3 H]iloprost (Amersham). After incubation at 30ЊC for tical Co (Tokushima, Japan), IL-6, G-CSF, and EPO by Chugai 1 hour, the reaction was terminated by an addition of 5 mL of icePharmaceutical Co (Tokyo, Japan), and IL-3, GM-CSF, and TPO cold 10 mmol/L Tris-HCl pH 7.4 buffer. This mixture was rapidly by Kirin Brewery Co (Maebashi, Japan). Phorbol 12-myristate 13-filtered through a Whatman GF/C filter (Whatman International, acetate (PMA) (Sigma) was added to the culture at a concentration Maidstone, UK). The filter was washed four times with 5 mL of the of 10 nmol/L. same buffer and the radioactivity was measured in 5 mL of Cleasol scintillation cocktail (Nacalai Tesque, Kyoto, Japan). Nonspecific
Northern Blot Analysis
binding was determined by the addition of 500-fold excess of unlaCells were harvested and total RNA was extracted by the acid beled iloprost to the incubation mixture. Cyclic (c)AMP Assay magnetic particle concentrator (MPC-6; Dynal) for 2 minutes and this procedure was repeated four to five times. Positively selected Cells were first preincubated with PMA or cytokines (IL-3, IL-6, GM-CSF, TPO, IL-1b, TNFa) for 24 hours, then incubated in a 24-cells were then resuspended in 100 mL of PBS(0) with 2% BSA plus 100 mL of DETACHaBEADS (Dynal). After a 45-minute incubation well microplate (Corning, NY) (1 1 10 5 cells/well) in 500 mL of RPMI1640 containing 0.5 mmol/L 3-isobutyl-1-methylxanthine under gentle rotation at room temperature, beads were released from cells by consecutive separation with a magnetic particle concentrator. (Sigma) and 0.1 % bovine serum albumin (BSA) (Sigma) at 37ЊC for 10 minutes then iloprost (Amersham, Buckinghamshire, UK), an Isolated cells were counted with a hemocytometer and cell viability was determined by trypan blue dye exclusion. The proportions of agonist of prostacyclin (final concentration: 100 nmol/L), or forskolin (Sigma; 1 mmol/L) was added to each well. Incubation was CD34 / cells in the isolated fraction were 78% to 85% as determined by the fluorescent microscopy (Olympus, Tokyo, Japan). Megakarycontinued for another 30 minutes. Because of the high instability of prostacyclin, we used the agonist. The reaction was terminated by ocytic colony formation was performed according to the method described previously 32 with some modifications. Briefly, CD34 / cells the addition of 500 mL of 12% trichloroacetic acid. The cAMP level was measured in triplicate using an 
Effect of Cytokines on the Expression of PGI 2 -R, PF4, and GPIIb Statistical Analysis
HEL and NS-Meg cells were challenged with various cy-
The differences in the values obtained were analyzed by the analysis of variance (ANOVA).
tokines as indicated in Fig 3A and TPO, IL-1b, and TNF-a upregulated the expression of PGI 2 -R, although intensity of the maximum expression induced and the time course by these stimuli differed depending on cytokines used and cell lines examined. The effect of IL1a was similar to IL-1b. G-CSF and EPO did not induce significant increases in PGI2-R expression (data not shown). The results obtained by densitometry are summarized in Fig  4. In HEL cells, both PF4 and GPIIb expression were enhanced by TPO, while in NS-Meg cells, which lack PF4, TPO intensified only GPIIb expression (Fig 3B) . All cytokines, except TPO, did not significantly increase the expression of PF4 or GPIIb mRNA in these cells (data not shown).
Induction of cAMP Synthesis by Iloprost and the Effect of PMA or Cytokines on cAMP Synthesis
We examined whether iloprost could induce postreceptor signal transduction through its specific receptor (ie, PGI 2 -R) coupled with Gs type guanosine triphosphate (GTP) binding protein. 7 Addition of iloprost to the cultures of HEL and NSMeg cells, which were shown to express PGI 2 -R, induced significant increases of cAMP ( Fig 5A) . Next we examined whether cAMP synthesis was increased following upregulation of PGI 2 -R. PMA pretreatment increased iloprost-induced cAMP synthesis 4.2-fold in HEL cells and 5.0-fold in NS-Meg cells when compared with nontreated cells. Pretreatment either with IL-3, IL-6, GM-CSF, TPO, IL-1b, or TNF-a also elevated iloprost-induced cAMP synthesis in HEL cells. All of the pretreatments (without iloprost) yielded tion time with iloprost from 15 to 60 minutes, and forskolin increased cAMP synthesis without significant difference beno significant increase of cAMP in the cells from each cell line when compared with nontreated cells (Fig 5A and B) .
tween PMA-or cytokine-pretreated cells and nontreated ones (Fig 5C) 
Semiquantitative RT-PCR for PGI 2 -R Expression in Megakaryocytic Colonies
We next extracted total RNA from each cell suspension. Evaluation of PGI 2 -R gene expression was performed by semiquantitative RT-PCR. We also assayed PF4 transcripts to compare with the kinetics of PGI 2 -R transcriptional levels. PGI 2 -R expression peaked on day 9, then declined toward day 14. In contrast, expression of PF4 increased towards day 14 (Fig 7) .
DISCUSSION
Prostacyclin synthesized mainly by arterial endothelial cells is the most potent inhibitor of platelet aggregation. This action is mediated through the specific receptor for prostacyclin. Because platelets possess only a small amount shown to express the receptor. Thus, the expression of PGI 2 -R was first demonstrated at the transcriptional level either in leukemic or normal megakaryocytes. (Fig 6) .
Effect of PMA or TPO on Binding Capacity of Iloprost to HEL and NS-Meg Cells

Normal Human Megakaryocytic Colonies
In methylcellulose semisolid cultures of cord blood CD34 / cells stimulated by TPO, we noted a number of megakaryocytic colonies consisting of more than 50 megakaryocytes, as early as 6 days after culture. The megakaryocytic nature of the colonies was confirmed by immunocytochemistry with anti-CD41a antibodies, as previously reported. 32 In accordance with the report by Nishihira et al, 33 we detected no other types of hemopoietic colonies until after 15 days of culture. On days 6, 9, and 14 of culture, more than 200 megakaryocytic colonies were plucked and pooled, respectively. Cytospin preparations were made from a part of each cell suspension and the diameter of individual cells was determined with a micrometer. The size of cells increased as the culture advanced; day 6, 16.74 { 4.33 mm (mean { For personal use only. on August 31, 2017. by guest www.bloodjournal.org From PMA, which is known to induce megakaryocytic maturaTaken together, IL-1-or TNF-a-induced upregulation of PGI 2 -R, as observed in this study, might act as a homeostatic tion, enhanced PGI 2 -R expression in megakaryocytic or megakaryocytic/erythroid cell lines with the upregulation of mechanism, preventing platelet aggregation in abnormal coagulopathy. However, PGI 2 -R upregulation was examined PF4 and GPIIb, a platelet-specific protein in a-granules and an adhesion molecule, respectively. TPO, the potent proonly in leukemic cells, thus the effect of proinflammatory cytokines on PGI 2 -R expression in normal megakaryocytes moter of megakaryocytopoiesis, exhibited similar effects. IL-3, IL-6, and GM-CSF, which are also known to induce or platelet awaits further clarification. megakaryocytic proliferation or maturation, enhanced PGI 2 -ACKNOWLEDGMENT R expression without significant enhancement of PF4 or cytes. This upregulation was not associated with the upregu- 
